Khalifa MM - Search Results

1

Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside.

Ashour OM, Naguib FN, Khalifa MM, Abdel-Raheem MH, Panzica RP, el Kouni MH. Ashour OM, et al. Among authors: khalifa mm. Cancer Res. 1995 Mar 1;55(5):1092-8. Cancer Res. 1995. PMID: 7866994

2

Investigation of the mechanisms underlying the gastroprotective effect of nicorandil.

Ismail HA, Khalifa MM, Hassan MK, Ashour OM. Ismail HA, et al. Among authors: khalifa mm. Pharmacology. 2007;79(2):76-85. doi: 10.1159/000097817. Epub 2006 Dec 7. Pharmacology. 2007. PMID: 17159379

3

Insights in the mechanisms underlying the anti-ulcer activity of nicorandil.

Ismail HA, Khalifa MM, Hassan MK, Ashour OM. Ismail HA, et al. Among authors: khalifa mm. Pharmazie. 2007 Jan;62(1):60-6. Pharmazie. 2007. PMID: 17294816

4

Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.

Hofni A, El-Moselhy MA, Taye A, Khalifa MM. Hofni A, et al. Among authors: khalifa mm. Eur J Pharmacol. 2014 Dec 5;744:173-82. doi: 10.1016/j.ejphar.2014.10.021. Epub 2014 Oct 27. Eur J Pharmacol. 2014. PMID: 25446917

5

Comparative effects of Aliskiren and Telmisartan in high fructose diet-induced metabolic syndrome in rats.

Rabie EM, Heeba GH, Abouzied MM, Khalifa MM. Rabie EM, et al. Among authors: khalifa mm. Eur J Pharmacol. 2015 Aug 5;760:145-53. doi: 10.1016/j.ejphar.2015.04.019. Epub 2015 Apr 25. Eur J Pharmacol. 2015. PMID: 25917321

6

Spironolactone improves endothelial dysfunction in streptozotocin-induced diabetic rats.

Adel H, Taye A, Khalifa MM. Adel H, et al. Among authors: khalifa mm. Naunyn Schmiedebergs Arch Pharmacol. 2014 Dec;387(12):1187-97. doi: 10.1007/s00210-014-1048-3. Epub 2014 Sep 20. Naunyn Schmiedebergs Arch Pharmacol. 2014. PMID: 25238812

7

Lixisenatide, a novel GLP-1 analog, protects against cerebral ischemia/reperfusion injury in diabetic rats.

Abdel-Latif RG, Heeba GH, Taye A, Khalifa MMA. Abdel-Latif RG, et al. Naunyn Schmiedebergs Arch Pharmacol. 2018 Jul;391(7):705-717. doi: 10.1007/s00210-018-1497-1. Epub 2018 Apr 18. Naunyn Schmiedebergs Arch Pharmacol. 2018. PMID: 29671019

8

Lixisenatide ameliorates cerebral ischemia-reperfusion injury via GLP-1 receptor dependent/independent pathways.

Abdel-Latif RG, Heeba GH, Taye A, Khalifa MMA. Abdel-Latif RG, et al. Eur J Pharmacol. 2018 Aug 15;833:145-154. doi: 10.1016/j.ejphar.2018.05.045. Epub 2018 Jun 1. Eur J Pharmacol. 2018. PMID: 29864411

9

Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats.

El-Deen RM, Heeba GH, Abdel-Latif RG, Khalifa MMA. El-Deen RM, et al. Fundam Clin Pharmacol. 2020 Jun;34(3):353-364. doi: 10.1111/fcp.12530. Epub 2020 Jan 14. Fundam Clin Pharmacol. 2020. PMID: 31885103

10

Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.

Heeba GH, El-Deen RM, Abdel-Latif RG, Khalifa MMA. Heeba GH, et al. Can J Physiol Pharmacol. 2020 Aug;98(8):498-505. doi: 10.1139/cjpp-2019-0487. Epub 2020 Feb 21. Can J Physiol Pharmacol. 2020. PMID: 32083947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters